作者: Ernest H.S. Choy , David L. Scott
DOI: 10.2165/00003495-199500501-00004
关键词: Rheumatoid arthritis 、 Oncology 、 Clinical significance 、 Rheumatoid factor 、 Magnetic resonance imaging 、 High morbidity 、 Pharmacotherapy 、 Internal medicine 、 Medicine 、 Osteoporosis 、 Pathology 、 Severe disease
摘要: Rheumatoid arthritis is characterised by a generally poor outcome and high morbidity, has variable course. Identifying those patients most likely to have prognosis of key clinical significance. Disease can be predicted from variety prognostic markers. Some these are simple demographic features the patients, include age, disease duration, gender. Others more specific rheumatoid arthritis, including presence early erosive changes on plain radiographs, factor titres, levels C-reactive protein, scores for activity. Although no single marker adequate specificity or sensitivity form basis decisions, several predictive severe disease. Thus, with damage who seropositive protein outcome. New markers imaging techniques become tools future. These genetic markers, combination magnetic resonance dual energy x-ray absorption scans localised osteoporosis.